These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11212103)

  • 1. The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type.
    Tian X; Hsin LW; Webster EL; Contoreggi C; Chrousos GP; Gold PW; Habib K; Ayala A; Eckelman WC; Jacobson AE; Rice KC
    Bioorg Med Chem Lett; 2001 Feb; 11(3):331-3. PubMed ID: 11212103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: the development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor.
    Hsin LW; Webster EL; Chrousos GP; Gold PW; Eckelman WC; Contoreggi C; Rice KC
    Bioorg Med Chem Lett; 2000 Apr; 10(8):707-10. PubMed ID: 10782669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptor.
    Martarello L; Kilts CD; Ely T; Owens MJ; Nemeroff CB; Camp M; Goodman MM
    Nucl Med Biol; 2001 Feb; 28(2):187-95. PubMed ID: 11295429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists.
    Hsin LW; Tian X; Webster EL; Coop A; Caldwell TM; Jacobson AE; Chrousos GP; Gold PW; Habib KE; Ayala A; Eckelman WC; Contoreggi C; Rice KC
    Bioorg Med Chem; 2002 Jan; 10(1):175-83. PubMed ID: 11738619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and pharmacological characterization of new highly selective CRF(2) antagonists: development of 123I-K31440 as a potential SPECT ligand.
    Rühmann A; Chapman J; Higelin J; Butscha B; Dautzenberg FM
    Peptides; 2002 Mar; 23(3):453-60. PubMed ID: 11835994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic visualization of corticotropin releasing hormone type 1 receptors with a nonpeptide ligand: synthesis of [(76)Br]MJL-1-109-2.
    Jagoda E; Contoreggi C; Lee MJ; Kao CH; Szajek LP; Listwak S; Gold P; Chrousos G; Greiner E; Kim BM; Jacobson AE; Rice KC; Eckelman W
    J Med Chem; 2003 Aug; 46(17):3559-62. PubMed ID: 12904058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new single-photon emission computed tomography (SPECT) imaging agent for serotonin transporters: [(125)I]Flip-IDAM, (2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanol.
    Zheng P; Lieberman BP; Ploessl K; Lemoine L; Miller S; Kung HF
    Bioorg Med Chem Lett; 2013 Feb; 23(3):869-72. PubMed ID: 23265880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists.
    Cocuzza AJ; Hobbs FW; Arnold CR; Chidester DR; Yarem JA; Culp S; Fitzgerald L; Gilligan PJ
    Bioorg Med Chem Lett; 1999 Apr; 9(7):1057-62. PubMed ID: 10230640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites.
    He XS; Bowen WD; Lee KS; Williams W; Weinberger DR; de Costa BR
    J Med Chem; 1993 Mar; 36(5):566-71. PubMed ID: 8496936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-affinity relationships of selective high-affinity 5-HT(4) receptor antagonists: application to the design of new potential single photon emission computed tomography tracers.
    Dubost E; Dumas N; Fossey C; Magnelli R; Butt-Gueulle S; Ballandonne C; Caignard DH; Dulin F; Sopkova de-Oliveira Santos J; Millet P; Charnay Y; Rault S; Cailly T; Fabis F
    J Med Chem; 2012 Nov; 55(22):9693-707. PubMed ID: 23102207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, binding affinity, radiolabeling, and microPET evaluation of 4-(2-substituted-4-substituted)-8-(dialkylamino)-6-methyl-1-substituted-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-ones as ligands for brain corticotropin-releasing factor type-1 (CRF1) receptors.
    Stehouwer JS; Bourke CH; Owens MJ; Voll RJ; Kilts CD; Goodman MM
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5111-4. PubMed ID: 26456805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a serotonin 4 receptor radiotracer with decreased lipophilicity for single photon emission computed tomography.
    Fresneau N; Dumas N; Tournier BB; Fossey C; Ballandonne C; Lesnard A; Millet P; Charnay Y; Cailly T; Bouillon JP; Fabis F
    Eur J Med Chem; 2015 Apr; 94():386-96. PubMed ID: 25778994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of substituted pyrimidines as corticotropin releasing factor (CRF) receptor ligands.
    Kuppast B; Spyridaki K; Liapakis G; Fahmy H
    Eur J Med Chem; 2014 May; 78():1-9. PubMed ID: 24675175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiopharmaceuticals for single-photon emission computed tomography brain imaging.
    Kung HF; Kung MP; Choi SR
    Semin Nucl Med; 2003 Jan; 33(1):2-13. PubMed ID: 12605353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [¹²⁵I]YP20: a novel radioligand specific for the extracellular domain of the CRF₁ receptor.
    Gordon JC; Edwards P; Elmore CS; Lazor LA; Paschetto K; Bostwick R; Sylvester M; Mauger R; Scott C; Aharony D
    Eur J Pharmacol; 2010 Dec; 649(1-3):59-63. PubMed ID: 20854803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-peptide corticotropin-releasing hormone antagonists: syntheses and structure-activity relationships of 2-anilinopyrimidines and -triazines.
    Arvanitis AG; Gilligan PJ; Chorvat RJ; Cheeseman RS; Christos TE; Bakthavatchalam R; Beck JP; Cocuzza AJ; Hobbs FW; Wilde RG; Arnold C; Chidester D; Curry M; He L; Hollis A; Klaczkiewicz J; Krenitsky PJ; Rescinito JP; Scholfield E; Culp S; De Souza EB; Fitzgerald L; Grigoriadis D; Tam SW; Shen HL
    J Med Chem; 1999 Mar; 42(5):805-18. PubMed ID: 10072679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Pyridyl ethers as SPECT radioligands for imaging nicotinic acetylcholine receptors.
    Henderson DJ; Eberl S; Thomson S; Smith A; Allan RD; Fulham MJ; Loiacono R; Kassiou M
    Appl Radiat Isot; 2004 May; 60(5):669-76. PubMed ID: 15082045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biodistribution of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate. A new ligand for the potential imaging of muscarinic receptors by single photon emission computed tomography.
    McPherson DW; DeHaven-Hudkins DL; Callahan AP; Knapp FF
    J Med Chem; 1993 Apr; 36(7):848-54. PubMed ID: 8464039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors.
    Cappelli A; Matarrese M; Moresco RM; Valenti S; Anzini M; Vomero S; Turolla EA; Belloli S; Simonelli P; Filannino MA; Lecchi M; Fazio F
    Bioorg Med Chem; 2006 Jun; 14(12):4055-66. PubMed ID: 16495062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and receptor binding properties of fluoro- and iodo-substituted high affinity sigma receptor ligands: identification of potential PET and SPECT sigma receptor imaging agents.
    de Costa B; Radesca L; Dominguez C; Di Paolo L; Bowen WD
    J Med Chem; 1992 Jun; 35(12):2221-30. PubMed ID: 1319493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.